Compare LXRX & SECZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LXRX | SECZ |
|---|---|---|
| Founded | 1995 | N/A |
| Country | United States | |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 996.7M | 1.0B |
| IPO Year | 2000 | 2026 |
| Metric | LXRX | SECZ |
|---|---|---|
| Price | $2.01 | $10.48 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $4.15 | N/A |
| AVG Volume (30 Days) | ★ 2.3M | 1.7M |
| Earning Date | 05-01-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 77.78 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $49,803,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 60.24 | N/A |
| 52 Week Low | $1.10 | $5.14 |
| 52 Week High | $2.68 | $13.20 |
| Indicator | LXRX | SECZ |
|---|---|---|
| Relative Strength Index (RSI) | 36.00 | 68.87 |
| Support Level | $1.50 | $6.15 |
| Resistance Level | $2.49 | N/A |
| Average True Range (ATR) | 0.08 | 0.67 |
| MACD | -0.02 | 0.27 |
| Stochastic Oscillator | 27.16 | 97.03 |
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.
Securitize Holdings Inc provides a platform for tokenized real-world assets specializing in tokenizing real-world assets (RWAs) like funds, equities, and fixed income on blockchain networks. The company operates across two primary verticals: i) Tokenization: It consists of on-chain infrastructure and tokenization & distribution, ii) Asset Servicing: It covers post-issuance transfer agent and fund management services. The majority of the company's revenue is derived from the Tokenization vertical.